Skip to Main Content

Author Details

Patricia Porter-Gill
Arkansas Children's Research Institute
1998
27
14
PMIDPaper TitleJournal TitlePublished Year
36455651Circulating microRNA levels differ in the early stages of insulin resistance in prepubertal children with obesity.Life Sci2023
36455651Circulating microRNA levels differ in the early stages of insulin resistance in prepubertal children with obesity.Life Sci2023
35743672Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report.J Pers Med2022
35455715Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting.J Pers Med2022
35743705Integrated microRNA-mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism.J Pers Med2022
35743672Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report.J Pers Med2022
35455715Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting.J Pers Med2022
35743705Integrated microRNA-mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism.J Pers Med2022
33236188A Pilot Comparison of High- Versus Low-Tech Palatability Assessment Tools in Young Children.Paediatr Drugs2021
34064668Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital.J Pers Med2021
33236188A Pilot Comparison of High- Versus Low-Tech Palatability Assessment Tools in Young Children.Paediatr Drugs2021
34575699MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation.J Pers Med2021
34575625Molecular Dysregulation in Autism Spectrum Disorder.J Pers Med2021
34575699MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation.J Pers Med2021
34575625Molecular Dysregulation in Autism Spectrum Disorder.J Pers Med2021
34064668Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital.J Pers Med2021
30976632Data on the effect of heat and other technical variables on the detection of microRNAs in human serum.Data Brief2019
30976632Data on the effect of heat and other technical variables on the detection of microRNAs in human serum.Data Brief2019
27621052Effects of a 28-day dietary co-exposure to melamine and cyanuric acid on the levels of serum microRNAs in male and female Fisher 344 rats.Food Chem Toxicol2016
27621052Effects of a 28-day dietary co-exposure to melamine and cyanuric acid on the levels of serum microRNAs in male and female Fisher 344 rats.Food Chem Toxicol2016
26134097Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.J Interferon Cytokine Res2015
26134097Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.J Interferon Cytokine Res2015
25320178The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.Cancer Res2014
25320178The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.Cancer Res2014
23291588A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.Nat Genet2013
23266392Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.J Natl Cancer Inst2013
23291588A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.Nat Genet2013
23266392Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.J Natl Cancer Inst2013
22403726Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.PLoS One2012
22416122Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.Proc Natl Acad Sci U S A2012
22403726Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.PLoS One2012
22228101Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.Hum Mol Genet2012
22228101Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.Hum Mol Genet2012
22416122Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.Proc Natl Acad Sci U S A2012
21814516A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.PLoS Genet2011
21814516A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.PLoS Genet2011
20482849NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.Mol Cancer2010
20482849NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.Mol Cancer2010
19330028Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.Nat Genet2009
19330028Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.Nat Genet2009
18025365Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.Arch Dermatol2007
18025365Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.Arch Dermatol2007
15753459Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.J Clin Oncol2005
15753459Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.J Clin Oncol2005
15304099Longitudinal assessment of the nevus phenotype in a melanoma kindred.J Invest Dermatol2004
15304099Longitudinal assessment of the nevus phenotype in a melanoma kindred.J Invest Dermatol2004
14629724Novel application of a fibrin cell block method to evaluate melanocytic cell populations.Pigment Cell Res2003
14629724Novel application of a fibrin cell block method to evaluate melanocytic cell populations.Pigment Cell Res2003
12123704In situ detection of phospholipid and phosphoinositide metabolism.Adv Enzyme Regul2002
12123704In situ detection of phospholipid and phosphoinositide metabolism.Adv Enzyme Regul2002
  • 1 - 50 of 54

Recommended Authors

Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 1
Abul Kalam Azad
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 18
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 0
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Peter White
The Ohio State University
Career Start Year 2000
Number of shared co-authors 1
David K Crossman
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 7
Chao Xing
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 1
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 2
Fahd Al-Mulla
Dasman Diabetes Institute
Career Start Year 1998
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 4
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 3
Wilson A Silva
Ribeirao Preto Medical School - University of Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
Joni L Rutter
National Center for Advancing Translational Sciences
Career Start Year 1993
Number of shared co-authors 6
Andrea Hofmann
Institute of Human Genetics, University of Bonn and Department of Genomics
Career Start Year 1991
Number of shared co-authors 0
Francisco M De La Vega
Stanford University School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Thomas J Hudson
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 13
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 5
Shrikant Mane
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 0
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 2
Brent W Zanke
University of Toronto
Career Start Year 1987
Number of shared co-authors 8
Hanna Rennert
New York NewYork-Presbyterian Hospital
Career Start Year 1986
Number of shared co-authors 1

Collaborators

Pingfu Fu
Case Western Reserve University
Co-authored papers 5
N??ria Malats
Spanish National Cancer Research Centre
Co-authored papers 3
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 3
Nilanjan Chatterjee
Co-authored papers 3
Margaret R Karagas
Co-authored papers 3
Joseph F Fraumeni
National Cancer Institute
Co-authored papers 3
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 3
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Demetrius Albanes
Co-authored papers 3
William R Diver
Co-authored papers 3
Jarmo Virtamo
Co-authored papers 3
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Lawrence C Brody
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Petra Lenz
Frederick National Laboratory for Cancer Research
Co-authored papers 2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Michael J Thun
Co-authored papers 2
David J Hunter
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 2
Constance Chen
Co-authored papers 1
Allison S Burrell
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 1
Phillip Buckhaults
University of South Carolina
Co-authored papers 1
Christopher A Haiman
University of Southern California
Co-authored papers 1
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 1
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 1
Stephanie J Weinstein
Co-authored papers 1
Wendy Westbroek
Salish Kootenai College
Co-authored papers 1
David V Conti
Co-authored papers 1
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Co-authored papers 1
Thomas R O'Brien
Co-authored papers 1
Release 1.2